US5847193AExpiredUtility
Labelled compound
Priority: Mar 24, 1995Filed: Mar 22, 1996Granted: Dec 8, 1998
Est. expiryMar 24, 2015(expired)· nominal 20-yr term from priority
A61K 2123/00A61K 51/0406
31
PatentIndex Score
2
Cited by
9
References
1
Claims
Abstract
The present invention provides a labelled beta -cyano-L-alanine and a gamma -cyano- alpha -aminobutyric acid, of which cyano group carbon is labelled with radionuclide 11C or 14C, or stable isotope 13C. The present invention also provides a labelled amino acids such as asparagine, asparatic acid, DABA, GABA, glutamine and glutamic acid synthesized by using the labelled beta -cyano-L-alanine and the gamma -cyano- alpha -aminobutyric acid as an intermediate. The labelled amino acids are useful for in vivo imaging of tumors and brain functions.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A labelled compound, which is β-cyano-L-alanine, a salt thereof or a derivative thereof having protecting group, of which cyano group carbon is labelled with positron nuclide 11 C.Join the waitlist — get patent alerts
Track US5847193A — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.